Labcorp to speak at the 41st annual J.P. Morgan Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 3, 2023-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10 at 4:30 p.m.

Advancing the health of underserved populations: How a lab can support community health initiatives

To learn more, watch the NAACOS webinar, featuring Linda Fraunhofer, Director of Population Health Initiatives at Labcorp.

Investing in the future of healthcare

Health and physician system leaders are facing unprecedented challenges while operating in an ever-evolving healthcare landscape. The Labcorp Venture Fund invests in early-stage private companies operating in strategic or adjacent spaces to develop novel solutions to important problems in health and healthcare.

Impact of the updated IPSS-molecular prognostic scoring system for myelodysplastic syndrome in 10,283 real world samples

Labcorp opens new Los Angeles based laboratory

New Space Will Be Three Times Larger and Increase Testing Capabilities BURLINGTON, N.C. --(BUSINESS WIRE)--Dec. 8, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in